1. Home
  2. HTOO vs APVO Comparison

HTOO vs APVO Comparison

Compare HTOO & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fusion Fuel Green PLC

HTOO

Fusion Fuel Green PLC

HOLD

Current Price

$2.72

Market Cap

9.6M

Sector

Utilities

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$4.75

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTOO
APVO
Founded
2020
2016
Country
Ireland
United States
Employees
131
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
8.3M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
HTOO
APVO
Price
$2.72
$4.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.0K
27.0K
Earning Date
02-28-2023
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.13
EPS
N/A
N/A
Revenue
N/A
$3,114,000.00
Revenue This Year
$4,832.46
N/A
Revenue Next Year
$81.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.50
52 Week High
$12.63
$10.70

Technical Indicators

Market Signals
Indicator
HTOO
APVO
Relative Strength Index (RSI) 37.77 48.73
Support Level $2.53 $4.29
Resistance Level $3.60 $5.59
Average True Range (ATR) 0.22 0.26
MACD -0.04 -0.01
Stochastic Oscillator 0.00 29.02

Price Performance

Historical Comparison
HTOO
APVO

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats. It earns majority revenue from UAE.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: